Free Trial

scPharmaceuticals (SCPH) Stock Price, News & Analysis

scPharmaceuticals logo
$3.92 +0.11 (+2.89%)
Closing price 04:00 PM Eastern
Extended Trading
$3.94 +0.02 (+0.38%)
As of 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About scPharmaceuticals Stock (NASDAQ:SCPH)

Key Stats

Today's Range
$3.78
$3.99
50-Day Range
$2.24
$4.27
52-Week Range
$1.94
$5.65
Volume
259,108 shs
Average Volume
372,342 shs
Market Capitalization
$206.94 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$14.00
Consensus Rating
Buy

Company Overview

scPharmaceuticals Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
92nd Percentile Overall Score

SCPH MarketRank™: 

scPharmaceuticals scored higher than 92% of companies evaluated by MarketBeat, and ranked 90th out of 943 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    scPharmaceuticals has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    scPharmaceuticals has received no research coverage in the past 90 days.

  • Read more about scPharmaceuticals' stock forecast and price target.
  • Earnings Growth

    Earnings for scPharmaceuticals are expected to grow in the coming year, from ($1.53) to ($1.08) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of scPharmaceuticals is -2.05, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of scPharmaceuticals is -2.05, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    scPharmaceuticals has a P/B Ratio of 14.52. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about scPharmaceuticals' valuation and earnings.
  • Percentage of Shares Shorted

    3.64% of the float of scPharmaceuticals has been sold short.
  • Short Interest Ratio / Days to Cover

    scPharmaceuticals has a short interest ratio ("days to cover") of 4.7.
  • Change versus previous month

    Short interest in scPharmaceuticals has recently decreased by 12.02%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    scPharmaceuticals does not currently pay a dividend.

  • Dividend Growth

    scPharmaceuticals does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    3.64% of the float of scPharmaceuticals has been sold short.
  • Short Interest Ratio / Days to Cover

    scPharmaceuticals has a short interest ratio ("days to cover") of 4.7.
  • Change versus previous month

    Short interest in scPharmaceuticals has recently decreased by 12.02%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    scPharmaceuticals has a news sentiment score of 1.87. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.88 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for scPharmaceuticals this week, compared to 2 articles on an average week.
  • Search Interest

    2 people have searched for SCPH on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • MarketBeat Follows

    12 people have added scPharmaceuticals to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, scPharmaceuticals insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 4.78% of the stock of scPharmaceuticals is held by insiders.

  • Percentage Held by Institutions

    89.52% of the stock of scPharmaceuticals is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about scPharmaceuticals' insider trading history.
Receive SCPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for scPharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

SCPH Stock News Headlines

How to Collect Up To $5,917/mo From Trump’s Made In USA Boom
How to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First policies, a historic wave of investment is flooding back into the United States: Apple committing a colossal $500 billion to build new U.S. factories. Microsoft injecting $80 billion into domestic manufacturing. Nvidia moving critical chip production back to America. But here's the hidden opportunity: There's now a groundbreaking way for you to start collecting monthly checks from these very same companies— checks that could reach as high as $5,917 each month. Don't miss your chance to participate directly in America's industrial comeback.
Q1 2025 scPharmaceuticals Inc Earnings Call
See More Headlines

SCPH Stock Analysis - Frequently Asked Questions

scPharmaceuticals' stock was trading at $3.54 at the beginning of the year. Since then, SCPH stock has increased by 10.7% and is now trading at $3.92.
View the best growth stocks for 2025 here
.

scPharmaceuticals, Inc. (NASDAQ:SCPH) issued its earnings results on Wednesday, May, 14th. The company reported ($0.34) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.28) by $0.06. The firm had revenue of $11.75 million for the quarter, compared to analysts' expectations of $11.63 million. scPharmaceuticals had a negative net margin of 216.24% and a negative trailing twelve-month return on equity of 594.07%.
Read the conference call transcript
.

scPharmaceuticals (SCPH) raised $96 million in an IPO on Friday, November 17th 2017. The company issued 6,400,000 shares at $14.00-$16.00 per share. Jefferies, Leerink Partners and BMO Capital Markets served as the underwriters for the IPO.

Shares of SCPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that scPharmaceuticals investors own include Voyager Therapeutics (VYGR), Waste Connections (WCN), American Water Works (AWK), The RMR Group (RMR), AU Optronics (AUOTY), DiamondRock Hospitality (DRH) and iShares Micro-Cap ETF (IWC).

Company Calendar

Last Earnings
5/14/2025
Today
7/01/2025
Next Earnings (Estimated)
8/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:SCPH
Fax
N/A
Employees
30
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$14.00
High Stock Price Target
$18.00
Low Stock Price Target
$12.00
Potential Upside/Downside
+259.4%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$85.15 million
Net Margins
-216.24%
Pretax Margin
-216.24%

Debt

Sales & Book Value

Annual Sales
$36.33 million
Price / Cash Flow
N/A
Book Value
$0.27 per share
Price / Book
14.43

Miscellaneous

Free Float
50,269,000
Market Cap
$205.62 million
Optionable
Optionable
Beta
0.36
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

This page (NASDAQ:SCPH) was last updated on 7/1/2025 by MarketBeat.com Staff
From Our Partners